Jennifer Mackenzie, MD
Family Medicine · Concord, NHNPI 1598259947
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.1% of the total across 120 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Novo Nordisk at 24.3% of the total. Among family medicine clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 120 payments — averaging $21.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$630
- Lilly USA, LLC$402
- Merck$268
- AstraZeneca$194
- Boehringer Ingelheim$190
- Astellas Pharma US Inc$159
- plus $747 from 13 others
What the payments were for
- Food & beverage$2,33390%
- Education$25510%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 32 | $630 |
| Lilly USA, LLC | 18 | $402 |
| Merck | 11 | $268 |
| AstraZeneca | 8 | $194 |
| Boehringer Ingelheim | 10 | $190 |
| Astellas Pharma US Inc | 4 | $159 |
| Exact Sciences | 6 | $119 |
| Pfizer | 6 | $113 |
| AbbVie | 5 | $112 |
| Amgen | 4 | $81 |
| Seqirus USA Inc | 4 | $75 |
| Phathom Pharmaceuticals, Inc. | 4 | $70 |
| Abbott | 2 | $45 |
| Cequr Corporation | 1 | $40 |
| Azurity Pharmaceuticals, Inc. | 1 | $24 |
| Vertex | 1 | $20 |
| Echosens North America, Inc. | 1 | $19 |
| Mylan Specialty L.p. | 1 | $16 |
| VBI Vaccine (delaware) Inc. | 1 | $14 |
How this compares
$2,589 in reported general payments places this provider in the 90th percentile of 397 family medicine providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 51 | $54,290 |
| EliquisApixaban | 41 | $45,628 |
| OzempicSemaglutide | 43 | $45,545 |
| JardianceEmpagliflozin | 35 | $42,773 |
| FarxigaDapagliflozin Propanediol | 23 | $22,617 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $15,747 |
| JanuviaSitagliptin Phosphate | 12 | $8,844 |
| XareltoRivaroxaban | 14 | $7,539 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 27 | $3,733 |
| Apidra SolostarInsulin Glulisine | 14 | $2,262 |
| Humalog Mix 75-25 KwikpenInsulin Lispro Protamin/Lispro | 13 | $2,058 |
| Tamsulosin Hcl | 85 | $1,993 |
| Atorvastatin Calcium | 257 | $1,922 |
| Pantoprazole Sodium | 67 | $1,329 |
| Levothyroxine Sodium | 124 | $1,306 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $402 | $54,29051 claims |
| PfizerEliquis | $113 | $45,62841 claims |
| Novo NordiskOzempic | $630 | $45,54543 claims |
| Boehringer IngelheimJardiance | $190 | $42,77335 claims |
| AstraZenecaFarxiga | $194 | $22,61723 claims |
| MerckJanuvia | $268 | $8,84412 claims |
| AbbVieSynthroid | $112 | $51812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 397 family medicine providers in New Hampshire.
Other family medicine in Concord
- Peter LoeserConcord$10K
- Jennifer BadgerConcord$4K
- Mathew SawyerConcord$3K
- Megan SullivanConcord$3K
- Patrick FoxConcord$3K
- Sabrina BolianitesConcord$3K
- Jeffrey CorbettConcord$2K
- Kenneth CallConcord$1K
- Mark BallentynePortsmouth$135K
- M LauterPortsmouth$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.